CNGA3 and achromatopsia: Molecular genetic analysis of ACHM patients reveals that, despite the discrepancy in the prevalence of CNGA3 gene variants among different ethnic groups, the majority of ACHM patients carry pathogenic variants in the cyclic nucleotide-gated channel 3 (CNGA3) gene (Solaki et al., 2022).